Evidence map›Paper›PMID 34617042›Full record

ArticleJVS-vascular science2020

Corrugated nanofiber tissue-engineered vascular graft to prevent kinking for arteriovenous shunts in an ovine model.

Hiroshi Matsushita, Takahiro Inoue, Sara Abdollahi, Enoch Yeung, Chin Siang Ong, Cecillia Lui, Isaree Pitaktong, Kevin Nelson, Jed Johnson, Narutoshi Hibino

Open access · goldAbstract read
In one paragraph

Article in JVS-vascular science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Great start predicts bright future forJVS-vascular science · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hiroshi MatsushitaDivision of Cardiac Surgery, Johns Hopkins Hospital, Baltimore, Md.
Takahiro InoueDivision of Cardiac Surgery, Johns Hopkins Hospital, Baltimore, Md.
Sara AbdollahiDivision of Cardiac Surgery, Johns Hopkins Hospital, Baltimore, Md.
Enoch YeungDivision of Cardiac Surgery, Johns Hopkins Hospital, Baltimore, Md.
Chin Siang OngDivision of Cardiac Surgery, Johns Hopkins Hospital, Baltimore, Md.
Cecillia LuiDivision of Cardiac Surgery, Johns Hopkins Hospital, Baltimore, Md.
Isaree PitaktongDivision of Cardiac Surgery, Johns Hopkins Hospital, Baltimore, Md.
Kevin NelsonNanofiber Solutions, LLC, Hilliard, Ohio.
Jed JohnsonNanofiber Solutions, LLC, Hilliard, Ohio.
Narutoshi HibinoDivision of Cardiac Surgery, Johns Hopkins Hospital, Baltimore, Md.
Johns Hopkins Hospital · USNanofiber Solutions (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveProsthetic grafts are often needed in open vascular procedures. However, the smaller diameter prosthetic grafts (<6 mm) have low patency and often result in complications from infection. Tissue-engineered vascular grafts (TEVGs) are a promising replacement for small diameter prosthetic grafts. TEVGs start as a biodegradable scaffold to promote autologous cell proliferation and functional neotissue regeneration. Owing to the limitations of graft materials; however, most TEVGs are rigid and easily kinked when implanted in limited spaces, which precludes clinical application. We have developed a novel corrugated nanofiber graft to prevent kinking.

methodsTEVGs with corrugated walls (5-mm internal diameter by 10 cm length) were created by electrospinning a blend of poly-ε-caprolactone and poly(L-lactide-co-caprolactone). The biodegradable grafts were then implanted between the carotid artery and the external jugular vein in a U-shape using an ovine model. TEVGs were implanted on both the left and right side of a sheep (n = 4, grafts = 8). The grafts were explanted 1 month after implantation and inspected with mechanical and histologic analyses. Graft patency was confirmed by measuring graft diameter and blood flow velocity using ultrasound, which was performed on day 4 and every following week after implantation.

resultsAll sheep survived postoperatively except for one sheep that died of acute heart failure 2 weeks after implantation. The graft patency rate was 87.5% (seven grafts out of eight) with one graft becoming occluded in the early phase after implantation. There was no significant kinking of the grafts. Overall, endothelial cells were observed in the grafts 1 month after the surgeries without graft rupture, calcification, or aneurysmal change.

conclusionsOur novel corrugated nanofiber vascular graft displayed neotissue formation without kinking in large animal model.

Indexed as

Arteriovenous shuntCorrugated nanofiber vascular graftLarge animal studySmaller diameter prosthetic graftsTissue-engineered vascular grafts

Identifiers

PMID34617042
PMCPMC8489245
OpenAlexW3015563300

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.